Marfan syndrome: new clues to genotype-phenotype correlations

被引:37
作者
Ramirez, F
Gayraud, B
Pereira, L
机构
[1] CUNY Mt Sinai Sch Med, Dept Biochem & Mol Biol, Brookdale Ctr, New York, NY 10029 USA
[2] Univ Sao Paulo, Ist Biociencias, Dept Biol, Sao Paulo, Brazil
关键词
connective tissue; dissecting aneurysm; elastic fibres; elastin; elastolysis; homologous gene targeting; inflammation; Marfan syndrome; microfibrils; mouse models of human diseases; vascular calcification;
D O I
10.3109/07853899909115979
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fibrillin 1 is the main constituent of extracellular microfibrils. Microfibrils can exist as inividual structures or associate with elastin to form elastic fibres. Fibrillin 1 mutations are the cause of the pleiotropic manifestations of the Marfan syndrome (MFS) which principally involve the musculoskeletal, ocular and cardiovascular systems. MFS pathogenesis requires high levels of mutant fibrillin 1 molecules with dominant-negative activity on microfibrillar assembly and function. Gene-targeting experiments in the mouse have shed new light on fibrillin 1 function, genotype-phenotype correlations and aneurysm progression. These experiments have documented the involvement of fibrillin 1 in mantaining tissue homeostasis, suggested the existence of a critical threshold of functional microfibrils for tissue biomechanics, and outlined novel contributors to the pathogenic sequence of vascular wall collapse.
引用
收藏
页码:202 / 207
页数:6
相关论文
共 31 条
[11]   Novel arterial pathology in mice and humans hemizygous for elastin [J].
Li, DY ;
Faury, G ;
Taylor, DG ;
Davis, EC ;
Boyle, WA ;
Mecham, RP ;
Stenzel, P ;
Boak, B ;
Keating, MT .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (10) :1783-1787
[12]   Elastin is an essential determinant of arterial morphogenesis [J].
Li, DY ;
Brooke, B ;
Davis, EC ;
Mecham, RP ;
Sorensen, LK ;
Boak, BB ;
Eichwald, E ;
Keating, MT .
NATURE, 1998, 393 (6682) :276-280
[13]  
Mecham RP, 1994, EXTRACELLULAR MATRIX, P281
[14]  
Morris CA, 1998, CURR OPIN CARDIOL, V13, P214
[15]  
Park ES, 1998, AM J MED GENET, V78, P350, DOI 10.1002/(SICI)1096-8628(19980724)78:4<350::AID-AJMG9>3.0.CO
[16]  
2-P
[17]   GENOMIC ORGANIZATION OF THE SEQUENCE CODING FOR FIBRILLIN, THE DEFECTIVE GENE-PRODUCT IN MARFAN-SYNDROME [J].
PEREIRA, L ;
DALESSIO, M ;
RAMIREZ, F ;
LYNCH, JR ;
SYKES, B ;
PANGILINAN, T ;
BONADIO, J .
HUMAN MOLECULAR GENETICS, 1993, 2 (07) :961-968
[18]   Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome [J].
Pereira, L ;
Andrikopoulos, K ;
Tian, J ;
Lee, SY ;
Keene, DR ;
Ono, R ;
Reinhardt, DP ;
Sakai, LY ;
Biery, NJ ;
Bunton, T ;
Dietz, HC ;
Ramirez, F .
NATURE GENETICS, 1997, 17 (02) :218-222
[19]   Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-l [J].
Pereira, L ;
Lee, SY ;
Gayraud, B ;
Andrikopoulos, K ;
Shapiro, SD ;
Bunton, T ;
Biery, NJ ;
Dietz, HC ;
Sakai, LY ;
Ramirez, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3819-3823
[20]   FIBRILLIN-2 (FBN2) MUTATIONS RESULT IN THE MARFAN-LIKE DISORDER, CONGENITAL CONTRACTURAL ARACHNODACTYLY [J].
PUTNAM, EA ;
ZHANG, H ;
RAMIREZ, F ;
MILEWICZ, DM .
NATURE GENETICS, 1995, 11 (04) :456-458